Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mashino

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Pharmacology|January 23, 2002
Effect of hexasulfobutylated C(60) on the isolated aortic ring of guinea pigShiang Suo Huang, Tadahiko Mashino, Masataka Mochizuki, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 4, 2014
[Laparoscopic repair of incarcerated diaphragmatic hernia as a late complication of laparoscopic right hepatectomy: a case report]Yusuke Yonemura, Kenji Umeda, Ryuichi Kumashiro, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitorDaisuke Yasuda, Akihiro Yuasa, Rika Obata, et al.
Nanoscale Research Letters|October 7, 2016
Potential Suppressive Effects of Two C<sub>60</sub> Fullerene Derivatives on Acquired ImmunityToshiro Hirai, Yasuo Yoshioka, Asako Udaka, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2018
Synthesis of novel benzbromarone derivatives designed to avoid metabolic activationTomoyuki Ohe, Ryutaro Umezawa, Yumina Kitagawara, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activityDaisuke Yasuda, Mao Nakajima, Akihiro Yuasa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]Keisei Anan, Maki Tanaka, Yasuteru Yoshinaga, et al.
The Journal of Dermatology|October 5, 2022
Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patientsJun Yamagami, Yuichi Kurihara, Takeru Funakoshi, et al.
Globalization and Health|February 21, 2024
Mapping study for health emergency and disaster risk management competencies and curricula: literature review and cross-sectional surveyKevin K C Hung, Makiko K MacDermot, Theresa S I Hui, et al.
Breast Cancer (Tokyo, Japan)|July 28, 2020
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) studyYutaka Yamamoto, Hiroyasu Yamashiro, Uhi Toh, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Pharmacology|January 23, 2002
Effect of hexasulfobutylated C(60) on the isolated aortic ring of guinea pigShiang Suo Huang, Tadahiko Mashino, Masataka Mochizuki, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 4, 2014
[Laparoscopic repair of incarcerated diaphragmatic hernia as a late complication of laparoscopic right hepatectomy: a case report]Yusuke Yonemura, Kenji Umeda, Ryuichi Kumashiro, et al.
Bioorganic & Medicinal Chemistry Letters|October 18, 2017
Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitorDaisuke Yasuda, Akihiro Yuasa, Rika Obata, et al.
Nanoscale Research Letters|October 7, 2016
Potential Suppressive Effects of Two C<sub>60</sub> Fullerene Derivatives on Acquired ImmunityToshiro Hirai, Yasuo Yoshioka, Asako Udaka, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2018
Synthesis of novel benzbromarone derivatives designed to avoid metabolic activationTomoyuki Ohe, Ryutaro Umezawa, Yumina Kitagawara, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activityDaisuke Yasuda, Mao Nakajima, Akihiro Yuasa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]Keisei Anan, Maki Tanaka, Yasuteru Yoshinaga, et al.
The Journal of Dermatology|October 5, 2022
Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patientsJun Yamagami, Yuichi Kurihara, Takeru Funakoshi, et al.
Globalization and Health|February 21, 2024
Mapping study for health emergency and disaster risk management competencies and curricula: literature review and cross-sectional surveyKevin K C Hung, Makiko K MacDermot, Theresa S I Hui, et al.
Breast Cancer (Tokyo, Japan)|July 28, 2020
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) studyYutaka Yamamoto, Hiroyasu Yamashiro, Uhi Toh, et al.
Pageof 16